Hillsdale Investment Management Inc.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1368465 Toronto, A6

Position in ENTA

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$5,500,491

-$1,159,180 QoQ

Shares Held

435,510

+3.1% QoQ

Ownership

1.50%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

7 quarters on record

Voting authority Sole 94.81068172946661.ToString("F0")% Shared 0.ToString("F0")% None 5.189318270533398.ToString("F0")%

Healthcare · as of Mar 31, 2026

Hillsdale Investment Management Inc. holds $85,671,146 across 25 Biotechnology names. ENTA ranks #6 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	167,742	$12,456,520
2	AXSM	Axsome Therapeutics, Inc.	53,363	$9,019,414
3	ZYME	Zymeworks Inc.	345,622	$8,654,374
4	HALO	Halozyme Therapeutics, Inc.	110,050	$7,112,531
5	MIRM	Mirum Pharmaceuticals, Inc.	59,730	$5,517,857
6	ENTA	Enanta Pharmaceuticals Inc This page	435,510	$5,500,491
7	TVTX	Travere Therapeutics, Inc.	182,320	$5,416,727
8	IONS	Ionis Pharmaceuticals Inc	70,900	$5,323,881

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,500,491	435,510	+3.1%	Shares	Sole	2026-05-04
2025-12-31	$6,659,671	422,300	+692.3%	Shares	Sole	2026-02-10
2022-12-31	$2,479,516	53,300	0.0%	Shares	Sole	2023-02-13
2022-09-30	$2,764,671	53,300	0.0%	Shares	Sole	2022-11-10
2022-06-30	$2,519,491	53,300	0.0%	Shares	Sole	2022-08-12
2022-03-31	$3,793,894	53,300	-1.2%	Shares	Sole	2022-04-28
2021-12-31	$4,034,381	53,950	—	Shares	Sole	2022-02-07
No filing history on record for this holder in this stock.